QA2022116 |
Atorvastatin-(anilide ring-d5) calcium salt
CAS# 265989-43-3
M.F.: C66H58D10CaF2N4O10
M.W.: 1165.42 |
|
|
QA2022114 |
Atorvastatin Impurity 114
CAS# NA
M.F.: C33H35FN2O7
M.W.: 590.65 |
|
|
QA2022113 |
Atorvastatin Impurity 113
CAS# NA
M.F.: C20H18FNO2
M.W.: 323.37 |
|
|
QA2022112 |
Atorvastatin Impurity 112
CAS# 666714-64-3
M.F.: C26H23FN2O
M.W.: 398.48 |
|
|
QA2022111 |
Atorvastatin Impurity 111
CAS# NA
M.F.: C33H35FN2O7
M.W.: 590.65 |
|
|
QA2022110 |
Atorvastatin Impurity 110
CAS# 887196-28-3
M.F.: C26H24FNO5
M.W.: 449.48 |
|
|
QA2022109 |
Atorvastatin Impurity 109
CAS# 1817798-20-1
M.F.: C26H24FNO3
M.W.: 417.48 |
|
|
QA2022108 |
Atorvastatin Impurity 108
CAS# 62148-67-8
M.F.: C14H10ClFO
M.W.: 248.68 |
|
|
QA2022107 |
Atorvastatin Impurity 107
CAS# NA
M.F.: C33H33FN2O6
M.W.: 572.63 |
|
|
QA2022106 |
Atorvastatin Impurity 106
CAS# NA
M.F.: C11H23NO4
M.W.: 233.30 |
|
|
QA2022105 |
Atorvastatin Impurity 105
CAS# NA
M.F.: C10H19NO4
M.W.: 217.26 |
|
|
QA2022104 |
Atorvastatin Impurity 104
CAS# NA
M.F.: C7H11NO4
M.W.: 173.17 |
|
|
QA2022103 |
Atorvastatin Impurity 103
CAS# 807312-27-2
M.F.: C10H15NO4
M.W.: 213.23 |
|
|
QA2022102 |
Atorvastatin Impurity 102
CAS# NA
M.F.: C31H48N2O8
M.W.: 576.72 |
|
|
QA2022101 |
Atorvastatin Impurity 101
CAS# NA
M.F.: C28H29NO3
M.W.: 427.53 |
|
|
QA2022100 |
Atorvastatin Impurity 100
CAS# 88675-31-4
M.F.: C14H10BrFO
M.W.: 293.13 |
|
|
QA202299 |
Atorvastatin Impurity 99
CAS# 134394-98-2
M.F.: C37H41FN2O5
M.W.: 612.73 |
|
|
QA202298 |
Atorvastatin EP Impurity J
CAS# NA
M.F.: C33H33FN2O4
M.W.: 540.62 |
|
|
QA202297 |
Atorvastatin 3-Deoxyhept-2Z-Enoic Acid Sodium Salt
CAS# 1659317-56-2;1191901-60-6(free base)
M.F.: C33H32FN2NaO4
M.W.: 562.61 |
|
|
QA202296 |
Atorvastatin Impurity 96
CAS# 125988-01-4
M.F.: C11H17NO4
M.W.: 227.26 |
|
|
QA202295 |
Atorvastatin Impurity 95
CAS# 791553-16-7(free base);131275-93-9(Na salt)
M.F.: C66H68CaF2N4O10
M.W.: 1155.34 |
|
|
QA202294 |
Atorvastatin Impurity 94
CAS# 887470-43-1(free base)
M.F.: C33H34FN2O7 1/2 Ca
M.W.: 589.63 20.04 |
|
|
QA202293 |
Atorvastatin Impurity 93
CAS# 186508-95-2
M.F.: C14H23NO4
M.W.: 269.34 |
|
|
QA202292 |
2-Hydroxy Atorvastatin Lactone-d5
CAS# 265989-50-2
M.F.: C33H28D5FN2O5
M.W.: 561.65 |
|
|
QA202291 |
Atorvastatin Impurity 91
CAS# NA
M.F.: C33H35FN2O7
M.W.: 590.64 |
|
|
QA202290 |
Atorvastatin oxirane
CAS# 1246818-88-1
M.F.: C26H24FNO3
M.W.: 417.47 |
|
|
QA202289 |
Atorvastatin Impurity 89
CAS# NA
M.F.: C39H39FN2O5
M.W.: 634.74 |
|
|
QA202288 |
Atorvastatin Impurity 88
CAS# 2243639-97-4
M.F.: C33H35FN2O5
M.W.: 558.64 |
|
|
QA202287 |
Atorvastatin Impurity 87
CAS# 1797905-42-0
M.F.: C26H24FNO3
M.W.: 417.47 |
|
|
QA202286 |
Atorvastatin Impurity 86
CAS# NA
M.F.: C28H51NO8
M.W.: 529.71 |
|
|
QA202285 |
Atorvastatin Impurity 85
CAS# 2299304-89-3
M.F.: C24H44N2O7
M.W.: 472.62 |
|
|
QA202284 |
ortho-Hydroxy Atorvastatin-d5 Calcium Salt
CAS# 265989-47-7
M.F.: C66H58D10CaF2N4O12
M.W.: 1197.40 |
|
|
QA202283 |
Atorvastatin-d5 Calcium Salt
CAS# 222412-82-0
M.F.: C66H58D10CaF2N4O10
M.W.: 1165.40 |
|
|
QA202281 |
Atorvastatin Impurity 81
CAS# NA
M.F.: C80H94CaF2N6O16
M.W.: 1473.71 |
|
|
QA202280 |
Atorvastatin Impurity 80
CAS# NA
M.F.: C33H33FN2O4
M.W.: 540.62 |
|
|
QA202279 |
Atorvastatin Impurity 79
CAS# 472967-95-6
M.F.: C40H47FN2O5
M.W.: 654.81 |
|
|
QA202278 |
Atorvastatin Impurity 78
CAS# 947249-30-1
M.F.: C40H47FN2O5
M.W.: 654.81 |
|
|
QA202277 |
Atorvastatin Impurity 77
CAS# 1105067-90-0
M.F.: C40H47FN2O5
M.W.: 654.81 |
|
|
QA202276 |
Atorvastatin Impurity 26
CAS# NA
M.F.: C40H47FN2O5
M.W.: 654.81 |
|
|
QA202275 |
Atorvastatin Impurity 25
CAS# NA
M.F.: C33H36FN3O4
M.W.: 557.66 |
|
|
QA202274 |
Atorvastatin Impurity 24
CAS# NA
M.F.: C66H60CaF2N4O6
M.W.: 1083.28 |
|
|
QA202273 |
Atorvastatin Impurity 23;Atorvastatin EP Impurity O
CAS# 887196-30-7
M.F.: C33H33FN2O5
M.W.: 556.62 |
|
|
QA202272 |
Atorvastatin Impurity 22
CAS# NA
M.F.: C52H58CaF2N2O8
M.W.: 917.10 |
|
|
QA202271 |
Atorvastatin Impurity 21
CAS# NA
M.F.: C26H24FNO5
M.W.: 449.47 |
|
|
QA202270 |
Atorvastatin Impurity 20
CAS# 906552-18-9;1046118-41-5(Ca salt); 148217-40-7(Na salt)
M.F.: C33H35FN2O6
M.W.: 574.64 |
|
|
QA202269 |
Atorvastatin Impurity 19
CAS# NA
M.F.: C33H33FN2O6
M.W.: 572.62 |
|
|
QA202268 |
Atorvastatin Impurity 18
CAS# NA
M.F.: C33H35FN2O6
M.W.: 574.64 |
|
|
QA202262 |
Atorvastatin Impurity 12
CAS# 196085-85-5
M.F.: C14H23NO4
M.W.: 269.34 |
|
|
QA202250 |
Atorvastatin Impurity Z
CAS# 196085-84-4
M.F.: C14H23NO4
M.W.: 269.34 |
|
|
QA202267 |
Atorvastatin Impurity 17
CAS# 425408-16-8
M.F.: C53H58ClFN4O9
M.W.: 949.50 |
|
|
QA202266 |
Atorvastatin Impurity 16
CAS# 1821498-27-4
M.F.: C27H30FNO6
M.W.: 483.53 |
|
|
QA202265 |
Atorvastatin Impurity 15
CAS# 887324-53-0;887196-29-4(Ca salt)
M.F.: C34H37FN2O5
M.W.: 572.67 |
|
|
QA202263 |
Atorvastatin Impurity 13
CAS# 1316291-19-6 (Na salt);873950-17-5
M.F.: C33H35FN2O7
M.W.: 590.64 |
|
|
QA202261 |
Atorvastatin Impurity 11
CAS# NA
M.F.: C44H56FN3O8
M.W.: 773.93 |
|
|
QA202234 |
Atorvastatin Impurity O
CAS# NA
M.F.: C37H42F2N2O5
M.W.: 632.74 |
|
|
QA202249 |
Atorvastatin Impurity Ⅵ
CAS# NA
M.F.: C37H44N2O5
M.W.: 596.76 |
|
|
QA202248 |
Atorvastatin Impurity Ⅴ
CAS# 1116118-82-1
M.F.: C50H64FN3O8
M.W.: 854.06 |
|
|
QA202247 |
Atorvastatin Impurity Ⅳ
CAS# 693793-87-2
M.F.: C40H46F2N2O5
M.W.: 672.80 |
|
|
QA202244 |
Atorvastatin Impurity Ⅲ
CAS# 1105067-91-1
M.F.: C40H48N2O5
M.W.: 636.82 |
|
|
QA202243 |
Atorvastatin Impurity Ⅱ
CAS# 125995-13-3
M.F.: C14H27NO4
M.W.: 273.37 |
|
|
QA202242 |
Atorvastatin Impurity Ⅰ
CAS# 125971-96-2
M.F.: C26H24FNO3
M.W.: 417.47 |
|
|
QA202260 |
Atorvastatin Impurity 10
CAS# 2088732-01-6
M.F.: C14H27NO4
M.W.: 273.37 |
|
|
QA202259 |
Atorvastatin Impurity 9
CAS# 1105067-89-7
M.F.: C14H27NO4
M.W.: 273.37 |
|
|
QA202258 |
Atorvastatin Impurity 8
CAS# 947586-93-8
M.F.: C14H27NO4
M.W.: 273.37 |
|
|
QA202257 |
Atorvastatin Impurity 7
CAS# 125971-94-0
M.F.: C14H23NO4
M.W.: 269.34 |
|
|
QA202256 |
Atorvastatin Impurity 6
CAS# 125971-93-9
M.F.: C11H19NO4
M.W.: 229.27 |
|
|
QA202255 |
Atorvastatin Impurity 5
CAS# 693793-82-7
M.F.: C26H23F2NO3
M.W.: 435.46 |
|
|
QA202254 |
Atorvastatin Impurity 4
CAS# 444577-70-2
M.F.: C26H25NO3
M.W.: 399.48 |
|
|
QA202253 |
Atorvastatin Impurity 3
CAS# 54016-70-5
M.F.: C8H14BrNOS
M.W.: 252.17 |
|
|
QA202252 |
Atorvastatin Impurity 2
CAS# 125971-57-5
M.F.: C19H19NO2
M.W.: 293.36 |
|
|
QA202251 |
Atorvastatin Impurity 1
CAS# 124401-38-3
M.F.: C12H15NO2
M.W.: 205.25 |
|
|
QA202202 |
Atorvastatin EP Impurity B
CAS# NA
M.F.: C33H34FN2O5 . 1/2Ca
M.W.: 577.67 |
|
|
QA202246 |
Atorvastatin EP Impurity E; USP Atorvastatin Related Compound E
CAS# 1105067-88-6
M.F.: C66H68CaF2N4O10
M.W.: 1155.34 |
|
|
QA202241 |
Atorvastatin Lactone Diepoxide
CAS# 1046118-40-4
M.F.: C33H33FN2O6
M.W.: 572.62 |
|
|
QA202240 |
Atorvastatin Impurity N
CAS# [NA]
M.F.: C33H34FN2O6(Free Base)
M.W.: 573.63(Free Base) |
|
|
QA202239 |
Atorvastatin Lactam Lactone
CAS# 906552-19-0
M.F.: C33H33FN2O5
M.W.: 556.62 |
|
|
QA202238 |
Atorvastatin Impurity L(Atorvastatin Cyclic Sodium Salt )
CAS# 1316291-19-6
M.F.: C33H34FN2NaO7
M.W.: 612.62 |
|
|
QA202237 |
Atorvastatin Impurity K
CAS# 265989-46-6;214217-86-4 (acid); 163217-75-2 (Na);1421760-64-6 (Na, 2H2O); 1581251-44-6 (2Na)
M.F.: C33H34FN2O6.1/2Ca
M.W.: 593.67 |
|
|
QA202236 |
Atorvastatin Impurity J
CAS# 265989-44-4
M.F.: C33H34FN2O6.1/2Ca
M.W.: 593.67 |
|
|
QA202235 |
Atorvastatin Epoxy Pyrrolooxazin Tricyclic Analog (USP)
CAS# NA
M.F.: C33H33FN2O6
M.W.: 572.62 |
|
|
QA202233 |
Atorvastatin FX1 Impurity
CAS# 1315629-79-8
M.F.: C33H34FN2NaO7
M.W.: 612.62 |
|
|
QA202232 |
Atorvastatin 4-Hydroxy Lactone
CAS# 163217-70-7
M.F.: C33H33FN2O5
M.W.: 556.62 |
|
|
QA202231 |
Atorvastatin 3-Oxo Methyl Ester
CAS# NA
M.F.: C33H35FN2O4
M.W.: 542.64 |
|
|
QA202230 |
Atorvastatin 2-Hydroxy Lactone
CAS# 163217-74-1
M.F.: C33H33FN2O5
M.W.: 556.62 |
|
|
QA202229 |
Atorvastatin Acetonide Methyl Ester
CAS# 1353049-81-6
M.F.: C37H41FN2O5
M.W.: 612.73 |
|
|
QA202228 |
Atorvastatin Lactone 3-O-Methyl Ether
CAS# NA
M.F.: C34H35FN2O4
M.W.: 554.65 |
|
|
QA202227 |
Atorvastatin 5-Oxo Acid
CAS# 1391052-82-6
M.F.: C33H33FN2O5
M.W.: 556.62 |
|
|
QA202226 |
Atorvastatin 4-Hydroxy Disodium Salt
CAS# 214217-88-6(free base)
M.F.: C33H33FN2Na2O6
M.W.: 618.60 |
|
|
QA202225 |
Atorvastatin 3-Oxo Acid Sodium Salt
CAS# 1391052-00-8
M.F.: C33H32FN2NaO5
M.W.: 578.61 |
|
|
QA202224 |
Atorvastatin 2-Hydroxy Sodium
CAS# 214217-86-4 (acid);163217-75-2; 265989-46-6 (1/2 Ca);1421760-64-6 (Na, 2H2O); 1581251-44-6 (2N
M.F.: C33H34FN2NaO6
M.W.: 596.62 |
|
|
QA202223 |
Atorvastatin (3S,5R)-Isomer Calcium
CAS# 887324-52-9
M.F.: C33H34FN2O5
M.W.: 557.63 |
|
|
QA202222 |
Atorvastatin Acetonide;Atorvastatin EP Impurity P
CAS# 581772-29-4
M.F.: C36H39FN2O5
M.W.: 598.7 |
|
|
QA202221 |
Atorvastatin Pyrrolidone Analog (USP); Atorvastatin EP Impurity Q
CAS# 148217-40-7;906552-18-9(free base); 1046118-41-5(Ca salt)
M.F.: C33H34FN2NaO6
M.W.: 596.62 |
|
|
QA202220 |
Atorvastatin 5-O-Methyl Sodium
CAS# NA
M.F.: C34H36FN2NaO5
M.W.: 594.65 |
|
|
QA202219 |
Atorvastatin Isopropyl Ester
CAS# NA
M.F.: C36H41FN2O5
M.W.: 600.72 |
|
|
QA202218 |
Atorvastatin Dehydro Lactone
CAS# 442851-50-5
M.F.: C33H31FN2O3
M.W.: 522.61 |
|
|
QA202217 |
Atorvastatin Dehydro Ethyl Ester
CAS# NA
M.F.: C35H37FN2O4
M.W.: 568.68 |
|
|
QA202216 |
Atorvastatin t-Butyl Ester;Atorvastatin EP Impurity N
CAS# 134395-00-9
M.F.: C37H43FN2O5
M.W.: 614.75 |
|
|
QA202215 |
Atorvastatin Methyl Ester;Atorvastatin EP Impurity K
CAS# 345891-62-5
M.F.: C34H37FN2O5
M.W.: 572.67 |
|
|
QA202214 |
Atorvastatin Ethyl Ester; Atorvastatin EP Impurity M
CAS# 1146977-93-6
M.F.: C35H39FN2O5
M.W.: 586.69 |
|
|
QA202213 |
Atorvastatin (3R,5S)-Isomer Sodium Salt
CAS# 131275-93-9; 791553-16-7(free base)
M.F.: C33H34FN2NaO5
M.W.: 580.62 |
|
|
QA202212 |
Atorvastatin 3-Deoxy-Hept-2-Enoic Acid (Sodium Salt) (USP)
CAS# 1105067-93-3(free base)
M.F.: C33H32FN2NaO4
M.W.: 562.61 |
|
|
QA202211 |
Atorvastatin Epoxy Tetrahydrofuran Analog (USP)
CAS# 873950-19-7
M.F.: C26H24FNO5
M.W.: 449.47 |
|
|
QA202210 |
Atorvastatin USP RC B (Calcium Salt)
CAS# 887196-25-0
M.F.: C66H68CaF2N4O10
M.W.: 1155.34 |
|
|
QA202209 |
Atorvastatin EP Impurity I; USP Atorvastatin Related Compound I
CAS# 125971-95-1
M.F.: C40H47FN2O5
M.W.: 654.81 |
|
|
QA202208 |
Atorvastatin EP Impurity H; USP Atorvastatin Related Compound H
CAS# 125995-03-1
M.F.: C33H33FN2O4
M.W.: 540.62 |
|
|
QA202207 |
Atorvastatin EP Impurity G
CAS# 887196-29-4;887324-53-0(free base)
M.F.: C34H36FN2O5·1/2Ca
M.W.: 591.74 |
|
|
QA202206 |
Atorvastatin EP Impurity F
CAS# 1105067-87-5;1371615-56-3(Na salt); 887196-24-9(free base)
M.F.: C40H47FN3O8·1/2Ca
M.W.: 736.86 |
|
|
QA202205 |
Atorvastatin USP Related Compound E
CAS# 501121-34-2(free base)
M.F.: C33H34FN2NaO5
M.W.: 580.62 |
|
|
QA202204 |
Atorvastatin EP Impurity D; USP Atorvastatin Related Compound D
CAS# 148146-51-4
M.F.: C26H22FNO4
M.W.: 431.46 |
|
|
QA202203 |
Atorvastatin EP Impurity C; USP Atorvastatin Related Compound C
CAS# 693793-53-2(calcium salt)
M.F.: C33H33F2N2NaO5
M.W.: 598.61 |
|
|
QA202201 |
Atorvastatin EP Impurity A; USP Atorvastatin Related Compound A
CAS# 433289-83-9;433289-84-0(free base)
M.F.: C66H70CaN4O10
M.W.: 1119.36 |
|
|
QA202200NA |
Atorvastatin Sodium
CAS# 134523-01-6
M.F.: C33H34FN2NaO5
M.W.: 580.62 |
|
|
QA202200CA |
Atorvastatin Calcium Trihydrate
CAS# 344423-98-9;134523-03-8(Ca salt)
M.F.: C66H74CaF2N4O13
M.W.: 1209.39 |
|
|
QA202200 |
Atorvastatin
CAS# 134523-00-5
M.F.: C33H35FN2O5
M.W.: 558.64 |
|
|
|